Confounders for interpreting the benefit of a biomarker-based strategy in early discontinuation of empirical antifungal therapy
Sign Up to like & getrecommendations! Published in 2018 at "Intensive Care Medicine"
DOI: 10.1007/s00134-018-5068-1
Abstract: Initial correspondence from Drs. Yamaga, Ohshimo and Shime We would like to discuss factors that potentially affect the results of a biomarker-based antifungal therapeutic algorithm in a recent issue of Intensive Care Medicine [1]. First,… read more here.
Keywords: medicine; antifungal therapy; confounders interpreting; biomarker based ... See more keywords